MDM2 INHIBITOR AMG-232 Uses, Dosage, Side Effects and more
MDM2 INHIBITOR AMG-232 is under investigation in clinical trial NCT03041688 (MDM2 Inhibitor MDM2 INHIBITOR AMG-232 and Decitabine in Treating Patients With Relapsed, Refractory, or Newly-Diagnosed Acute Myeloid Leukemia).
| Trade Name | MDM2 INHIBITOR AMG-232 |
| Generic | AMG-232 |
| AMG-232 Other Names | MDM2 INHIBITOR AMG-232 |
| Type | |
| Formula | C28H35Cl2NO5S |
| Weight | Average: 568.55 Monoisotopic: 567.1612998 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
